Evidence-based longevity medicine, n=1 trials, 82-organ rejuvenation.
A 13-bet capital allocation thesis: prize capital, organ-specific rejuvenation trials, and biostasis as the terminal optionality bet, engineered for peer-reviewed evidence of multi-organ age reversal by 2030.
From Lp(a) and free testosterone to CBCT airway imaging and 24/7 blood pressure, the longevity tests routinely skipped in standard care, with how to access them.
Evidence-based longevity medicine, n=1 trial design, and 82-organ rejuvenation, explained without hype.